HomeTNGX • NASDAQ
add
Tango Therapeutics Inc
Previous close
$8.56
Day range
$8.64 - $9.15
Year range
$2.88 - $13.03
Market cap
948.79M USD
Avg Volume
814.53K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 6.47M | 12.23% |
Operating expense | 10.66M | 33.05% |
Net income | -37.91M | -35.37% |
Net profit margin | -585.91 | -20.62% |
Earnings per share | -0.35 | -9.37% |
EBITDA | -41.63M | -40.14% |
Effective tax rate | -0.11% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 343.60M | 2.99% |
Total assets | 406.22M | 0.61% |
Total liabilities | 141.77M | -19.68% |
Total equity | 264.45M | — |
Shares outstanding | 106.85M | — |
Price to book | 3.45 | — |
Return on assets | -26.12% | — |
Return on capital | -35.53% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -37.91M | -35.37% |
Cash from operations | -37.86M | -8.45% |
Cash from investing | -11.20M | -135.51% |
Cash from financing | 42.98M | 58,779.45% |
Net change in cash | -6.08M | -85.14% |
Free cash flow | -21.18M | -19.57% |
About
Founded
2017
Headquarters
Website
Employees
140